查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1870841

牛健康管理市場按產品類型、通路、牛品種、疾病類型、給藥途徑和應用進行分類－2025年至2032年全球預測

Cattle Health Market by Product Type, Distribution Channel, Cattle Type, Disease Type, Route Of Administration, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，牛健康市場規模將達到 123.2 億美元，複合年成長率為 5.76%。

關鍵市場統計數據
基準年 2024 78.7億美元
預計年份：2025年 83.3億美元
預測年份 2032 123.2億美元
複合年成長率 (%) 5.76%

對重新定義現代畜牧管理中牛健康優先事項、臨床實踐和農場層面決策的因素進行了簡要的背景概述。

牛健康管理領域正處於一個十字路口，科學進步、法規演變和農業經濟變化在此交匯融合，重新定義了生產者和服務提供者如何優先考慮動物福利、生產力和生物安全。在此背景下，價值鏈上的所有相關人員必須協調改進疾病預防和診斷技術的需求與勞動力供應、供應鏈韌性以及對抗菌藥物管理日益重視等實際限制因素。本導言透過識別影響產品需求、分銷選擇和農場層級決策轉變的因素，為後續分析提供了一個框架。

診斷創新、抗菌藥物管理、不斷變化的配送模式和精準管理如何重塑產品選擇、臨床路徑和農場韌性

在科學進步、監管調整和相關人員期望變化的推動下，牛健康管理領域正經歷著多重變革。診斷技術的快速發展，包括實驗室檢測和攜帶式快速檢測套組，使得細菌性、病毒性和寄生蟲性疾病的早期檢測成為可能，從而支持更有針對性的治療和預防干涉措施。同時，對抗菌藥物管理的持續重視加速了替代治療方法和預防措施的推廣應用，並推動了飼料添加劑配方的發展，這些配方提供酵素、益生元、益生菌、維生素和礦物質，以增強牛的免疫力和代謝穩定性。

近期關稅措施對牛健康價值鏈採購、供應連續性和籌資策略的營運和策略影響

美國近期採取的關稅措施為依賴進口的牛保健供應鏈環節帶來了新的挑戰，導致成本結構和籌資策略發生變化。依賴跨境採購活性成分、診斷劑、特殊疫苗成分和某些飼料添加劑的製造商和經銷商被迫重新評估供應商關係，實現採購來源多元化，並在某些情況下加快本地化生產，以維持供應的連續性和利潤的穩定。這些因應措施促使企業重新關注供應鏈規劃、供應商選擇和庫存策略，以降低關稅帶來的衝擊。

明確按產品、通路、牛類類別、疾病、給藥途徑和應用方式進行細分如何指導採購行為和創新重點。

細分市場分析揭示了影響購買行為和產品開發重點的細微需求促進因素，這些因素涵蓋產品類型、分銷管道、牛類類別、疾病分類、給藥途徑和應用領域。在產品類型中，診斷領域呈現兩極分化的格局：實驗室檢測用於支援確診和監測項目，而快速檢測套組則用於支援農場和診所的現場決策。消毒劑和殺菌劑在需要嚴格生物安全措施的地區受到優先考慮，而飼料添加劑則包括酵素、益生元、益生菌以及用於全面改善消化效率和免疫能力的維生素和礦物質。

了解影響產品引進和供應鏈設計的區域性法規結構、生產系統和分銷動態差異

區域趨勢對牛健康管理的法規結構、疾病流行情況、生產系統和商業策略有顯著影響。在美洲，一體化的商業性營運、先進的獸醫基礎設施以及不斷變化的消費者期望，推動了對高效疫苗、精準診斷以及配套藥品和飼料添加劑的需求，促使供應商將可追溯性和性能數據作為差異化優勢。在歐洲、中東和非洲地區，不同的監管規定和生產規模導致了產品應用模式的差異。有些市場優先考慮高科技診斷和嚴格的抗​​生素監管，而有些市場則需要對成本敏感的配方和完善的低溫運輸物流來應對地方性疾病的壓力。

競爭洞察：整合產品供應、證據產生和經銷夥伴如何定義牛健康市場的領導地位

牛健康領域的競爭動態呈現出多元化的態勢，既有跨國製藥公司，也有專業動物保健公司、診斷創新企業和新興飼料添加劑專家。主要企業透過整合疫苗、標靶藥物、診斷技術和技術服務，提供端到端的牛健康解決方案，脫穎而出，深受具有前瞻性思維的養殖戶青睞。同時，規模較小、更靈活的公司則傾向於專注於細分市場，例如快速照護現場診斷、新型益生菌配方或針對地方性病原體的社區疫苗平台。

為製造商和經銷商提供切實可行、影響深遠的策略性舉措，以增強韌性、加速產品推廣並改善縣級健康結果。

行業領導者應優先採取一系列行動，以把握不斷變化的市場需求，同時降低營運風險。首先，投資診斷能力建設，以支持農場快速決策，並將診斷結果轉化為可操作的治療和預防通訊協定。其次，加速採購和生產多元化，以降低貿易中斷帶來的風險，同時加強供應商選擇標準和庫存策略，以確保供應的連續性。

採用透明的混合方法研究途徑，結合相關人員訪談、監管審查和比較分析，以支持可操作的牛健康見解。

本分析整合了來自行業相關人員訪談的定性和定量資訊、二手文獻綜述以及對監管和貿易趨勢的比較評估，從而對牛健康趨勢提供了全面而平衡的觀點。主要研究包括與獸醫、產品經理、分銷主管和農場經理進行結構化對話，以收集有關診斷使用模式、治療偏好和採購行為的實地見解。這些直接觀察結果與公開的監管文件、疾病管理和藥理學方面的科學文獻以及檢驗的公司資訊披露進行了三角驗證，以確保其準確性。

將策略性問題與診斷技術、合理應用和供應鏈韌性相結合：從而實現牛健康管理的永續改進

總之，牛健康產業正經歷積極的變革時期期，診斷技術的進步、管理的重要性以及分銷管道的創新正在重塑商業性和臨床規範。那些能夠整合產品開發、供應鏈韌性以及與獸醫和生產者開展循證合作的企業，將更有利於影響技術應用並改善動物福利。由於區域差異和關稅等因素，供應方面的考量凸顯了製定客製化策略和靈活採購的重要性，以維持業務的連續性和競爭力。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 擴大精準畜牧監測技術在疾病早期檢測的應用
  • 牛飼料中對植物性抗生素和益生菌等抗生素替代品的需求不斷成長
  • 擴巨量資料驅動決策支援平台在畜群健康管理的應用
  • 增加遠距遠端照護解決方案的投資，用於遠距獸醫診斷和治療
  • 更重視以福利為中心的牛運輸通訊協定，以最大程度地減少與壓力相關的健康問題
  • 運用區塊鏈技術提升整個供應鏈中疾病控制的可追溯性
  • 監管改革旨在鼓勵減少抗菌藥物使用並促進負責任的抗菌藥物管理。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的牛健康管理市場

  • 診斷
    • 實驗室檢測
    • 快速檢測套組
  • 消毒劑和清潔劑
  • 飼料添加劑
    • 酵素
    • 益生元和益生菌
    • 維生素和礦物質
  • 製藥
    • 驅蟲藥
    • 抗發炎藥
    • 抗生素
    • 激素和生長促進劑
  • 疫苗
    • 細菌
    • 寄生蟲
    • 病毒性的

第9章牛健康管理市場（依通路分類）

  • 農資供應商店
  • 線上管道
  • 藥局
  • 獸醫醫院和診所

第10章 按牛隻類型分類的牛保健市場

  • 牛
  • 牛
  • 牛

第11章 依疾病類型分類的牛健康管理市場

  • 細菌性疾病
  • 代謝性疾病
  • 寄生蟲病
  • 生殖疾病
  • 呼吸系統疾病
  • 病毒性疾病

第12章 按給藥途徑分類的牛保健市場

  • 吸入
  • 注射
  • 口服
  • 外用

第13章牛健康管理市場：依應用領域分類

  • 促進生長
  • 營養補充
  • 預防
  • 繁殖管理
  • 治療

第14章牛健康管理市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章牛健康管理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國牛健康管理市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Elanco Animal Health Incorporated
    • Ceva Sante Animale SA
    • Virbac SA
    • Dechra Pharmaceuticals PLC
    • Vetoquinol SA
    • Phibro Animal Health Corporation
    • Neogen Corporation
Product Code: MRR-1A1A064C0406

The Cattle Health Market is projected to grow by USD 12.32 billion at a CAGR of 5.76% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.87 billion
Estimated Year [2025] USD 8.33 billion
Forecast Year [2032] USD 12.32 billion
CAGR (%) 5.76%

A concise contextual overview of the forces redefining cattle health priorities, clinical practice, and farm-level decision-making in modern animal management

The cattle health landscape is at a crossroads where scientific progress, regulatory evolution, and shifting farm economics are converging to redefine how producers and service providers prioritize animal welfare, productivity, and biosecurity. In this context, stakeholders across the value chain must reconcile the push for improved disease prevention and diagnostics with practical constraints such as labor availability, supply chain resilience, and rising emphasis on antimicrobial stewardship. This introduction frames the subsequent analysis by clarifying the forces shaping product demand, influencing distribution choices, and altering farm-level decision-making.

This report centers on the tangible intersections between innovation and implementation: how laboratory and point-of-care diagnostics are altering clinical workflows; how feed additives and targeted pharmaceuticals are being integrated into herd health plans; and how vaccines, both established and emerging, are being deployed to mitigate infectious and parasitic challenges. By establishing this baseline, readers will gain a clear understanding of why certain intervention categories are gaining prominence and how institutional and farm-level priorities are adapting in response to animal health imperatives and market pressures.

Throughout the ensuing sections, we connect strategic implications to operational realities, helping executives, product managers, and veterinarians align R&D, commercial planning, and on-the-ground practices to improve cattle health outcomes while managing cost and compliance considerations.

How diagnostic innovation, antimicrobial stewardship, distribution evolution, and precision management are reshaping product selection, clinical pathways, and farm resilience

The landscape of cattle health is experiencing several transformative shifts driven by scientific advances, regulatory recalibration, and changing stakeholder expectations. Rapid improvements in diagnostics technology, including laboratory testing and portable rapid test kits, are enabling earlier detection of bacterial, viral, and parasitic conditions, which in turn supports more targeted therapeutic and preventive interventions. Simultaneously, continued emphasis on antimicrobial stewardship is accelerating adoption of alternative therapeutics and preventive measures, incentivizing growth in feed additive formulations that deliver enzymes, prebiotics, probiotics, vitamins, and minerals to support immunity and metabolic stability.

Distribution models are evolving as well, with online channels complementing traditional farm supply outlets, pharmacies, and veterinary hospitals to improve accessibility and traceability of products. Regulatory scrutiny around hormones and growth promoters, coupled with heightened consumer interest in sustainable and welfare-oriented production, is prompting manufacturers to diversify portfolios toward vaccines and non-antibiotic therapeutic options. In parallel, data-driven herd management and precision livestock farming techniques are informing product selection and administration routes, with injectable, oral, topical, and inhalation options being deployed in more strategic and condition-specific ways.

Taken together, these shifts signal a move from broad, reactive interventions toward integrated, preventive, and data-informed strategies that prioritize herd resilience, product safety, and long-term viability for producers and value chain partners.

Operational and strategic consequences of recent tariff measures on sourcing, supply continuity, and procurement strategies across the cattle health value chain

Recent tariff actions in the United States introduced new considerations for import-dependent segments of the cattle health supply chain, altering cost structures and procurement strategies. Manufacturers and distributors that rely on cross-border sourcing for active pharmaceutical ingredients, diagnostic reagents, specialized vaccine components, and certain feed additive raw materials have had to reassess supplier relationships, diversify sourcing footprints, and, in some instances, accelerate localization of production to maintain supply continuity and margin stability. These operational responses have translated into renewed emphasis on supply chain mapping, vendor qualification, and inventory strategies to reduce exposure to tariff-driven disruptions.

At the same time, regulatory agencies and trade partners are adapting to the changed trade environment through procedural clarifications and bilateral dialogues intended to minimize unintended consequences for animal health inputs. The net effect for industry participants is a heightened need for commercial agility: procurement teams are pursuing multi-sourcing and strategic stockholding while product managers are evaluating reformulation opportunities that reduce reliance on tariff-sensitive inputs. Veterinary service providers and farm operators are also adjusting purchasing cadence and product selection, preferring accessible distribution channels that mitigate delivery risks.

In short, tariffs have reinforced the strategic importance of resilient value chains, compelling companies across the cattle health ecosystem to invest in sourcing flexibility, supplier partnerships, and near-term operational contingency planning to safeguard animal care and business continuity.

Clarifying how product, channel, cattle category, disease, administration route, and application segmentation combine to direct purchasing behavior and innovation priorities

Segmentation analysis reveals nuanced demand drivers across product types, distribution channels, cattle categories, disease classes, administration routes, and applications, each shaping purchasing behavior and product development priorities. Within product categories, diagnostics present a bifurcated landscape where laboratory testing supports confirmatory and surveillance programs while rapid test kits enable point-of-care decision-making on farms and in clinics. Disinfectants and sanitizers are prioritized where biosecurity protocols are stringent, and feed additives span enzymes, prebiotics and probiotics, plus vitamins and minerals that collectively address digestive efficiency and immune competence.

Pharmaceutical portfolios require careful segmentation: anthelmintics remain essential for parasite control, anti-inflammatories address acute clinical needs, antibiotics are increasingly subject to stewardship constraints, and hormones and growth promoters face regulatory and market scrutiny that influence adoption. Vaccines span bacterial, parasitic, and viral targets and are central to preventive herd health strategies. Distribution patterns show that farm supplies outlets continue to be primary procurement points for routine products, while online channels are expanding accessibility and transactional efficiency; pharmacies and veterinary hospitals and clinics play critical roles for prescription and professionally administered interventions.

Cattle types-beef, calves, and dairy-exhibit distinct health management priorities linked to production cycles, nutrition, and disease susceptibility, driving divergent demand for formulation types and administration routes. Disease-type segmentation underscores the breadth of clinical focus areas, from bacterial and viral infections to parasitic and metabolic disorders and reproductive and respiratory conditions, each requiring tailored diagnostic, preventive, and therapeutic approaches. Administration routes-injectable, oral, topical, and inhalation-must align with product pharmacokinetics, ease of use on farm, and welfare considerations. Finally, applications ranging from growth promotion and nutritional supplementation to preventive, reproductive management, and therapeutic uses determine how products are positioned commercially and integrated into herd health programs.

Understanding regional variation in regulatory frameworks, production systems, and distribution dynamics that shape product adoption and supply chain design

Regional dynamics exert a strong influence on regulatory frameworks, disease prevalence, production systems, and commercial strategies in cattle health. In the Americas, integrated commercial operations, advanced veterinary infrastructure, and evolving consumer expectations drive demand for high-efficacy vaccines, precision diagnostics, and stewardship-aligned pharmaceuticals and feed additives, prompting suppliers to emphasize traceability and performance data as differentiators. Across Europe, the Middle East and Africa, regulatory diversity and varied production scales mean that product adoption patterns diverge: some markets prioritize high-tech diagnostics and stringent antibiotic regulations, while others require cost-sensitive formulations and robust cold-chain logistics to manage endemic disease pressures.

Asia-Pacific presents distinct dynamics with rapid modernization of dairy and beef systems, heterogeneous disease burdens, and expanding distribution ecosystems where online channels and veterinary clinics are increasingly influential. Regional procurement and supply chain approaches reflect these conditions: manufacturers adapt packaging, formulations, and support services for diverse cold-chain capabilities, veterinary capacity, and farm management practices. Moreover, public and private sector disease control programs and regional trade policies shape vaccine deployment strategies and prioritize interventions that address prevalent bacterial, viral, and parasitic challenges.

Understanding these regional nuances enables companies to align product development, registration strategies, and commercial engagement to the specific needs of producers, veterinarians, and regulators in each geography, thereby improving adoption and impact.

Competitive landscape insights highlighting how integrated product offerings, evidence generation, and distribution partnerships define leadership in cattle health markets

Competitive dynamics in the cattle health space reflect a mix of multinational pharmaceutical firms, specialized animal health companies, diagnostic innovators, and emerging feed additive specialists. Leading players differentiate through integrated offerings that combine vaccines, targeted pharmaceuticals, diagnostics, and technical services, enabling end-to-end herd health solutions that resonate with progressive producers. Meanwhile, smaller, agile firms often focus on niche opportunities such as rapid point-of-care diagnostics, novel probiotic blends, or localized vaccine platforms that address region-specific pathogens.

Collaboration between manufacturers and veterinary services is a growing strategic priority, with companies investing in field trials, real-world evidence generation, and educational programs to demonstrate product value and encourage protocol adoption. Strategic partnerships with distribution networks, including online platforms and veterinary hospitals, are expanding reach and streamlining procurement, while investments in cold-chain logistics and regulatory affairs capabilities help accelerate market entry and maintain product integrity. Additionally, companies are increasingly transparent about stewardship commitments and data transparency, which strengthens trust with veterinarians, producers, and regulators.

Going forward, competitive advantage will accrue to organizations that combine technical innovation with robust supply chain safeguards, evidence-based engagement, and services that lower adoption friction for farm operators and clinical practitioners.

Practical, high-impact strategic moves for manufacturers and distributors to strengthen resilience, accelerate adoption, and improve herd-level health outcomes

Industry leaders should pursue a set of prioritized actions to capitalize on evolving demand while reducing operational risk. First, invest in diagnostic capabilities that support rapid, on-farm decision-making and link diagnostic outputs to actionable treatment and prevention protocols. Second, accelerate diversification of sourcing and production to reduce exposure to trade-related disruptions, while strengthening supplier qualification and inventory strategies to maintain continuity of supply.

Third, reframe product portfolios to emphasize antimicrobial stewardship and non-antibiotic interventions, pairing therapeutics with vaccination strategies and targeted feed additives that support immune resilience and metabolic health. Fourth, deepen engagement with distribution partners across farm supply outlets, online channels, pharmacies, and veterinary hospitals to enhance accessibility and ensure appropriate product use. Fifth, tailor regional go-to-market approaches that reflect the distinct regulatory, logistical, and disease prevalence conditions in the Americas, Europe Middle East & Africa, and Asia-Pacific, and invest in localized trials and educational outreach to support adoption.

Finally, augment competitive positioning by generating robust field data, leveraging digital tools for herd-level insights, and offering service-oriented solutions that simplify adoption. Taken together, these steps will enable companies to deliver higher value, mitigate operational risk, and align product strategy with the practical needs of veterinarians and producers.

Transparent mixed-methods research approach combining stakeholder interviews, regulatory review, and comparative analysis to support actionable cattle health insights

This analysis synthesizes qualitative and quantitative inputs drawn from primary interviews with industry stakeholders, secondary literature review, and comparative assessment of regulatory and trade developments to ensure a comprehensive and balanced perspective on cattle health dynamics. Primary research included structured conversations with veterinary practitioners, product managers, distribution executives, and farm operators to capture on-the-ground insights into diagnostic use patterns, treatment preferences, and procurement behaviors. These firsthand observations were triangulated with public regulatory documentation, scientific literature on disease management and pharmacology, and validated company disclosures to enhance accuracy.

The methodology emphasizes transparency and replicability: sources were documented, thematic coding was applied to interview data, and cross-validation checks were conducted to reconcile divergent viewpoints. Where appropriate, scenario analysis was used to assess operational responses to trade and supply chain disruptions, while technology and adoption trends were evaluated through product pipeline reviews and stakeholder readiness assessments. This mixed-methods approach ensures the findings reflect both technical realities and commercial practicalities relevant to decision-makers across the cattle health ecosystem.

Synthesis of strategic imperatives emphasizing diagnostics, stewardship, and supply chain resilience to guide sustainable improvements in cattle health management

In conclusion, the cattle health sector is navigating a period of constructive disruption where diagnostic advances, stewardship imperatives, and distribution innovations are reshaping commercial and clinical norms. Companies that align product development, supply chain resilience, and evidence-based engagement with veterinarians and producers will be better positioned to influence adoption and improve animal welfare outcomes. Regional heterogeneity and tariff-induced supply considerations underscore the importance of tailored strategies and sourcing flexibility to maintain continuity and competitiveness.

The practical implications for stakeholders are clear: prioritize diagnostics and preventive measures that reduce reliance on broad-spectrum therapeutics, invest in formulation and logistics that suit local production systems, and cultivate partnerships that bring clinical credibility and distribution efficiency. By translating these insights into coordinated action-spanning R&D prioritization, supplier diversification, and targeted market engagement-industry participants can address immediate operational challenges while building sustainable pathways for long-term improvement in cattle health.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of precision livestock monitoring technologies for early disease detection
  • 5.2. Rising demand for antibiotic alternatives such as phytogenics and probiotics in cattle feed
  • 5.3. Introduction of next generation mRNA vaccines targeting bovine respiratory diseases
  • 5.4. Increasing utilization of data-driven decision support platforms for herd health management
  • 5.5. Expanding investments in telemedicine solutions for remote veterinary diagnostics and treatment
  • 5.6. Enhanced focus on welfare-driven cattle transport protocols to minimize stress-induced health issues
  • 5.7. Integration of blockchain technology for traceable disease control across supply chains
  • 5.8. Regulatory shifts incentivizing reduced antimicrobial usage and promoting responsible stewardship

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cattle Health Market, by Product Type

  • 8.1. Diagnostics
    • 8.1.1. Laboratory Testing
    • 8.1.2. Rapid Test Kits
  • 8.2. Disinfectants & Sanitizers
  • 8.3. Feed Additives
    • 8.3.1. Enzymes
    • 8.3.2. Prebiotics & Probiotics
    • 8.3.3. Vitamins & Minerals
  • 8.4. Pharmaceuticals
    • 8.4.1. Anthelmintics
    • 8.4.2. Anti-Inflammatories
    • 8.4.3. Antibiotics
    • 8.4.4. Hormones & Growth Promoters
  • 8.5. Vaccines
    • 8.5.1. Bacterial
    • 8.5.2. Parasitic
    • 8.5.3. Viral

9. Cattle Health Market, by Distribution Channel

  • 9.1. Farm Supplies Outlets
  • 9.2. Online Channels
  • 9.3. Pharmacies
  • 9.4. Veterinary Hospitals & Clinics

10. Cattle Health Market, by Cattle Type

  • 10.1. Beef
  • 10.2. Calves
  • 10.3. Dairy

11. Cattle Health Market, by Disease Type

  • 11.1. Bacterial Diseases
  • 11.2. Metabolic Disorders
  • 11.3. Parasitic Diseases
  • 11.4. Reproductive Disorders
  • 11.5. Respiratory Disorders
  • 11.6. Viral Diseases

12. Cattle Health Market, by Route Of Administration

  • 12.1. Inhalation
  • 12.2. Injectable
  • 12.3. Oral
  • 12.4. Topical

13. Cattle Health Market, by Application

  • 13.1. Growth Promotion
  • 13.2. Nutritional Supplementation
  • 13.3. Preventive
  • 13.4. Reproductive Management
  • 13.5. Therapeutic

14. Cattle Health Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Cattle Health Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Cattle Health Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Zoetis Inc.
    • 17.3.2. Merck & Co., Inc.
    • 17.3.3. Boehringer Ingelheim International GmbH
    • 17.3.4. Elanco Animal Health Incorporated
    • 17.3.5. Ceva Sante Animale SA
    • 17.3.6. Virbac SA
    • 17.3.7. Dechra Pharmaceuticals PLC
    • 17.3.8. Vetoquinol SA
    • 17.3.9. Phibro Animal Health Corporation
    • 17.3.10. Neogen Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CATTLE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CATTLE HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. CATTLE HEALTH MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. CATTLE HEALTH MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CATTLE HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CATTLE HEALTH MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CATTLE HEALTH MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL CATTLE HEALTH MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL CATTLE HEALTH MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS CATTLE HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
  • TABLE 335. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 336. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)

TABL